Patent ID: 7084108

Claim:
A compound of Formula I, wherein A is a Met-AP2 inhibitory core; W is O or NR 2 ; R 1 and R 2 are each, independently, hydrogen or alkyl; X is alkylene or substituted alkylene; n is 0 or 1; R 3 and R 4 are each, independently, hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl; or R 3 and R 4 , together with the carbon atom to which they are attached, form a carbocyclic or heterocyclic group; or R 3 and R 4 together form an alkylene group; Z is —C(O)— alkylene or alkylene—C(O)—; and P is a peptide comprising from 1 to about 100 amino acid residues attached at its amino terminus to Z or a group OR 5 or N(R 6 )R 7 , wherein R 5 , R 6 and R 7 are each, independently, hydrogen, alkyl, substituted alkyl, azacycloalkyl or substituted azacycloalkyl; or R 6 and R 7 , together with the nitrogen atom to which they are attached, form a substituted or unsubstituted heterocyclic ring structure; or Z is —O—, —NR 8 —, alkylene-O— or alkylene-NR 8 —, where R 8 is hydrogen or alkyl; and P is hydrogen, alkyl or a peptide consisting of from 1 to about 100 amino acid residues attached at its carboxy terminus to Z; wherein the N-terminus of the peptide is —NR 2 R 3 , wherein R 2 , is hydrogen, alkyl or arylalkyl and R 3 , is hydrogen, alkyl, arylalkyl or acyl.